Intellia Therapeutics (NTLA) PT Lowered to $86 at SVB Leerink
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $11.75 -0.68%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Mani Foroohar lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $86.00 (from $90.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
